Engineering Host–Guest Interactions for Next‐Generation Heparin Biosensors
Small · 2026-09 · 22 (51)
DOI: 10.1002/smll.74588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 29.07.2026. Verfasst von Frank Boateng Osei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Oakland University, Rochester, Michigan, USA. Hauptthemen laut MEDLINE: Heparin, Biosensing Techniques. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Heparin, a polyanionic anticoagulant, is widely used clinically but requires neutralization to restore normal blood coagulation. Protamine sulfate ( PS ) is the standard antidote, yet limitations exist. Herein, a polycationic, cavity‐containing pillar[6]arene macrocycle ( P12+ ) demonstrates superior heparin neutralization in physiological media compared to its lower‐valency analog P10+ , and performance comparable to PS . MTT assays reveal low toxicity of the P12+ , suggesting feasibility for in vivo use. Dynamic light scattering reveals that P12+ forms nanoscale complexes below 400 nm, smaller than PS ‐heparin aggregates. Remarkably, P12+ exhibits enhanced neutralization of low‐molecular‐weight heparin, a known limitation of PS . Additionally, heparin detection is achieved via a host–guest indicator displacement assay (IDA) using methyl orange ( MO ). UV–vis studies show ∼80% MO release with P12+ , compared to ∼40% with P10+ in the presence of heparin. This response is detectable in undiluted human plasma for P12+ , whereas P10+ shows a suitable response in 5% diluted plasma. A fluorescence‐based IDA enables sensitive detection down to 0.11 U/mL, below the therapeutic range (0.80–2.00 U/mL). Molecular dynamics simulations support these findings, revealing that weaker host–guest interactions and favorable electrostatics in P12+ facilitate efficient MO release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Oakland University, Rochester, Michigan, USA.
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, Texas, USA.
- Department of Biological Sciences, Oakland University, Rochester, Michigan, USA.
- Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
ORCID-Profile: Charles Mariasoosai, Sahar Heidari, Kwaku Twum, Hedieh Torabifard, Ngong Kodiah Beyeh
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NIH/NIGMS
- National Science Foundation
Zitieren
APA
Osei, F. B., Mariasoosai, C., Christodolu, Z., Caringi, C., Heidari, S., Twum, K., Nanjappa, S., Trivedi, E., Washington, A. V., Torabifard, H., & Beyeh, N. K. (2026). Engineering Host–Guest Interactions for Next‐Generation Heparin Biosensors. Small, 22(51). https://doi.org/10.1002/smll.74588
Vancouver
Osei FB, Mariasoosai C, Christodolu Z, Caringi C, Heidari S, Twum K, et al. Engineering Host–Guest Interactions for Next‐Generation Heparin Biosensors. Small. 2026;22(51). doi:10.1002/smll.74588
BibTeX
@article{Osei2026,
author = {Osei, Frank Boateng and Mariasoosai, Charles and Christodolu, Zackary and Caringi, Chloe and Heidari, Sahar and Twum, Kwaku and Nanjappa, Sithara and Trivedi, Evan and Washington, A Valance and Torabifard, Hedieh and Beyeh, Ngong Kodiah},
title = {Engineering Host–Guest Interactions for Next‐Generation Heparin Biosensors},
journal = {Small},
year = {2026},
volume = {22},
number = {51},
doi = {10.1002/smll.74588}
}
EUVIMED